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INTRODUCTION
everal epidemiological studies on miner cohorts of under-
ground mines have demonstrated that exposure to radon
decay products increases the lung cancer risk of miners (1-4). On
the basis of these studies, in 1988 radon decay products1 were
classified by the International Agency for Research on Cancer, of
the World Health Organization, as Group 1 carcinogens, i.e., sub-
stances for which there is sufficient evidence of carcinogenicity
based on human studies (5). 
The health impact of the risk extrapolated from miners to the gen-
eral population was very high, due to the widespread presence of
radon in indoor air of workplaces and dwellings, and many thou-
sands of lung cancers were attributed to residential radon expo-
sure (e.g. 6). As a consequence, many countries and internation-
al organizations introduced recommendations and regulations to
limit radon exposure in workplaces and/or in dwellings (1,7-9).
However, many uncertainties affected the extrapolation of the risk
from miners to the general population, including the followings: i)
the average radon concentration in mines were about 100 times
higher than in dwellings, although the average exposure, which
takes into account both radon concentration and the occupancy,
were about 10 times more than in dwellings, due to the longer
time spent at home; ii) the composition of the inhaled air in
dwellings is quite different from that in mines, which contains also
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The risk estimates for the general population extrapolated from the risk obtained from the
miner studies leaded many national and international health organizations to estimate that
residential exposure to radon and its decay products can be considered one of the main
lung cancer risks after the tobacco smoking, which is responsible of a very large fraction
of the total number of lung (and other) cancers. Due to this health relevance and to uncer-
tainties in the extrapolation from studies on miners, many residential case-controls stud-
ies have been conducted in Europe, North America and China, are shortly reviewed in this
paper. Most of these studies estimated an increased risk, proportional to the radon expo-
sure, although a statistical significance of the estimated risk was reached only in few
studies or restricted analyses, due to the low statistical power related to the relatively
small study size and the presence of not negligible uncertainties in the evaluated radon
exposure. The effects of these uncertainties were analyzed in some studies, and it was
estimated to reduce the risk by 50% to 100%. Moreover, some restricted analyses
showed that selecting subjects with a presumably better evaluation of radon exposure,
for example with radon measurement covering all the exposure period of interest, the
estimated risk increases by a factor of about two. The use of retrospective dosimetry
compared with contemporary radon concentration measurements produce higher risks,
too. In most of the studies a multiplicative interaction between tobacco smoking and
radon is suggested, which implies that the lung cancer risk due to radon exposure is
much higher for a smoker, compared with the risk for a never-smoker. More precise and
definitive results are expected from pooled analysis. The just published pooled analyses
of two Chinese studies and seven North American estimate a (slightly) significant excess
odds ratio of 14% and 11% respectively. A more precise and comprehensive assessment
is expected from the forthcoming results of the European pooling of 13 studies and the
following pooling of all the studies. Other studies will be probably needed to answer some
question on the risk for never-smokers and the interaction with passive smoking.
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Sother risk factors for lung cancer, such as arsenic; iii) the char-
acteristics of the exposed groups are quite different, because
miners are only men with strong constitution, whereas general
population include both men and women of all ages and consti-
tutions (3,4,10-11).
Therefore, epidemiological studies on residential exposure to
radon and lung cancer risk, generally with a case-control design,
were conducted in order to estimate the risk without the need of
extrapolation. In this paper a concise review of these studies is
presented.
SOME METHODOLOGICAL ISSUES
Effect of (and correction for) exposure uncertainty
Due to the relatively low radon concentration in dwellings, com-
pared with values in mines, the residential radon health effects are
more difficult to be highlighted. Exposure uncertainty (also called
error) can affect very significantly the estimates of relative risks
lower than 2. Being generally non-differential, exposure uncer-
tainty not only adds an extra uncertainty in the estimated risk, but
also introduces a bias, i.e. it produces an underestimate of the
real risk and reduces the statistical power of the study (12-14). A
differential bias was also attributed to measurement errors (15).
Great efforts are needed in these studies to obtain high accuracy
and precision of radon concentration measurements. However,
only for few studies a detailed quality assurance program for
radon measurements has been implemented (16,17). In some
studies, the observed risks were corrected to take into account
the estimated uncertainty on radon exposure. Such corrections
increase the estimated risk compared to the observed one, but
necessarily widen the confidence intervals (12,14). 
Duration of radon concentration measurements
Radon concentration has significant time variations, and average
values in winter are generally greater than in summer. For this
reason, 12-month measurements have been adopted in most of
the case-controls studies in order to average seasonal variations,
while shorter (2-6 months) measurements are expected to be
affected by larger errors. Seasonal correction factors have been
applied in some studies to obtain unbiased yearly average radon
concentration (18); however such correction factors take into
account the average seasonal variations of radon concentration,
which actually can be quite different from one house to another,
depending on radon source behavior and living habits.
Statistical analysis
In residential case-control studies, average radon concentration in
the period of interest (generally from 3-5 to 20-35 years before
the occurrence of lung cancer) is generally used as a measure of
radon exposure. Most of the studies included both a categorical
and a continuous analysis of data. In the categorical analysis,
odds ratios (OR), which are a good approximation of relative risk,
are related to radon concentrations grouped in categories, with
the lowest category used as reference. With this approach,
results are sensitive to the choice of both the reference and the
other exposure categories, and extreme exposure values affect
OR of the highest category only. In the continuous analysis,
excess odds ratios (EOR) are calculated through regression with
radon concentration as a continuous variable, generally using a
linear function of exposure or of the logarithm of exposure. The
results obtained with these two functions are very similar for
radon concentrations up to about 400 Bq m-3.With this approach,
results are more "objective" because they do not depend on the
chosen categories, however they are quite sensitive to extreme
high radon concentration values. Recently, more flexible analysis
methods have been developed, in order to overcome the limits of
the previous classical approaches, and a good review has recent-
ly been published (19). However, these modern methods are
beyond the scope of this short review and have not been gener-
ally applied to the analysis of residential case-control studies, yet.
For shortness purpose, only the results of continuous analyses,
referred to a radon concentration of 100 Bq m-3, will be reported
in this paper.
Retrospective dosimetry
In most studies the radon exposure in periods up to 35 years
before the index year (i.e. the year of lung cancer diagnosis for
cases or the year of enrollment for controls) is generally evaluat-
ed on the basis of contemporary measurements of radon con-
centration, assumed to be the equal to that one in the period of
interest. This assumption is a potential major source of exposure
uncertainty, because present (contemporary) radon concentra-
tion could be quite different from past vales, due to changes of the
building structure or of the living habits (especially in case of dif-
ferent inhabitants), which can affect radon entry and ventilation
and therefore radon concentration values. In order to avoid this
assumption, an alternative retrospective technique has been
developed (20-21). This technique is based on the measurement
of surface activity of 210Po implanted in glass surfaces. The mea-
sured 210Po activity comes from the deposition of radon decay
products on such surfaces and the implantation due to the recoil
energy of 218Po or 214Po. The following decay product, 210Pb
(with an half-life of 22.3 years), remains trapped in a thin layer
due to the characteristics of glass, so that the alpha particle emit-
ted from the following decay product, 210Po, can escape the
glass and be detected. In conclusion, the present measured 210Po
surface alpha activity is related to the past radon concentration in
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20the room integrated over many years. This retrospective tech-
nique was applied in three case-control studies (22-24), and in
two ones the results have been published and were very interest-
ing, as shown in the following section.
RESULTS AND DISCUSSION
The summary results of the main published case-control studies
on residential radon exposure and lung cancer risk are reported in
Table 1, and will be shortly discussed in the followings.
Early studies on residential radon and lung cancer
Early studies on residential radon and lung cancer, e.g. those car-
ried out in Sweden and Canada (25-28), were generally of small
size and mostly based on proxy of radon exposure, such as the
type of dwelling, building materials and the soil characteristics.
Due to these characteristics these studies have not been includ-
ed in meta-analyses or pooled-analyses and their results are not
reported in Table 1. Nevertheless, these studies were very useful
to highlight the radon issue and to improve the design of follow-
ing studies.
First group of studies with systematic measurement of resi-
dential radon concentration
The results of the first case-control studies with extensive and
systematic experimental evaluation of radon exposure were quite
different, from large EORs to negative EORs (see Table 1). Due to
the large debate arisen from these controversial results more
large studies were started with similar design in order to be easi-
ly pooled (55). Anyway, a meta-analysis of the first eight studies
with more than 200 cases each (29-33,35-38) was published in
1997, estimating an overall EOR=0.09, at 100 Bq m-3 -3, which
was slightly statistically significant (95%CI=0.01,0.19) (56).
Moreover, the results obtained analyzing the subset of miners
exposed at radon exposure levels comparable to residential ones
were very similar (57). However, the meta-analysis confirmed the
heterogeneity among the studies, which was possibly due to the
different adjustment for confounding factors, which cannot be
resolved in a meta-analysis, but only with a pooled analysis.
Therefore these results could not be considered conclusive.
Residential radon and lung cancer
21
Table 1. Summary of case-control studies on residential radon and lung cancerThe second group of case-control studies
The case-control studies published after the meta-analysis of
Lubin and Boice gave generally results more homogeneous. Both
the design and the analysis of most of these studies were largely
discussed in international meetings and in international collabora-
tions, in order to make easier a comparison and to prepare a large
data pooling. Only in the large study in Western Germany an
EOR<0 was estimated, but this was probably due to the con-
comitance of some specific factors, such as: the low radon con-
centration; the low number of years of interest covered by mea-
surements, because only the current dwelling was measured; the
presence of a non-differential bias (42,15). On the other extreme
of the range, in the small sized N-W Spain study a risk much high-
er than in the other studies was estimated, however the value
reported in Table 1 was actually derived from the published cate-
gorical analysis results, which were driven by the chosen refer-
ence category (48). A real continuous analysis, which was not
included in the published paper, would probably give quite differ-
ent results.
In some studies (Sweden-I, S-W England, Gansu), radon expo-
sure uncertainty was evaluated and the observed EOR was cor-
rected to take into account such uncertainty (34,39,50). The cor-
rected EOR increased by a factor in the range 50% to 100% (see
Table1). The uncertainty evaluations were generally quite approx-
imate, but the significant increase of the risk estimates underlines
the importance to take into account exposure uncertainty for a
correct evaluation of the radon heath impact.
Restricted analyses
Besides the results with all the subjects, some results with
restricted data set are also reported in Table 1. In two studies,
Missouri-I and Iowa (35, 41), a higher risk was estimated for live
subjects: whereas in the Missouri-I no clear explanation was
given, in the second study this results was attributed to the better
memory of subjects (compared with their next-of-skin) regarding
the time spent in the different floors of their home, where the mea-
sured radon concentration resulted quite different. In other words,
a more accurate exposure evaluation for the living subjects was
given as explanation of their higher risk.
Another important restricted analysis is related to the measure-
ment coverage of the period of interest (see Table 1). In fact,
some studies (showed that when subjects with a high or com-
plete coverage are selected, a quite higher risk is obtained. This
result demonstrates again the effect of exposure uncertainty on
the risk estimates. The results obtained with radon retrospective
dosimetry represent another demonstration of the importance of
the exposure evaluation. In fact, in two studies (Missouri-II and
Sweden-II) the EOR estimated on the basis of radon exposure
evaluated with retrospective techniques was quite higher than that
one obtained with contemporary radon concentration measure-
ments (see Table 1), suggesting that the former evaluation is
more accurate (40,44).
Radon-smoking interaction
The statistical power for evaluating the radon-smoking interaction
was generally low for these studies. However, in many of them
the OR, or the EOR, for never-smokers were similar to that for
smokers, suggesting a multiplicative interaction (e.g.33). This
result is somewhat different from that derived from the miner
studies, where a less-than-multiplicative interaction was estimat-
ed, with a relative risk for never-smokers equal to about 2 to 3
higher than that for smokers (3,4). However, these miner study
results were based on few subjects with adequate smoking data
(3,4). A multiplicative interaction has a very important conse-
quence: due to the high lung cancer risk of a smoker compared
to that one of a never-smoker, the absolute increase of risk due
to the same radon exposure is much higher for a smoker than for
a never-smoker. Moreover, the results of the recent Swedish-II
study on never-smokers suggest that a synergistic interaction
could exist between radon and passive smoking, too (43); how-
ever, larger studies are necessary to confirm this conclusion.
CONCLUSIONS AND PERSPECTIVES
Most of the case-control studies estimate an increased risk due
to residential radon exposure, although the increase is generally
not statistically significant. The estimated risk is generally higher
when exposure uncertainties are reduced or taken into account. 
More precise results and a better comparison of different studies
can be obtained from pooled analyses of groups of studies. Two
very recent pooled analyses have been published: i) the pooling
of two Chinese studies, which included the published Shenyang
and Gansu studies, with a total of 1076 cases and 2015 controls
(58-59); ii) the pooling of seven North-American studies, which
included the following studies: New Jersey, Missouri-I, Winnipeg,
Missouri-II, Iowa, Connecticut, Utah-South Idaho, with a total of
4081 cases and 5281 controls (58,60). The estimated EOR at
100 Bq m-3 were 0.14 (95% CI=0.01,0.37) and 0.11 (95%
CI=0.00,0.28) for and the Chinese and the North American stud-
ies, respectively, and no statistically significant difference among
studies was observed. The restricted analysis on subjects with
complete dosimetry for the 5-30 y exposure period prior to inter-
view showed higher risks, with EOR= 0.28 (95% CI=0.07,0.75)
and EOR=0.21 (95% CI=0.03,0.50). These results were consis-
tent with extrapolations from miner studies. Other excellent
reviews of residential case-control studies were recently pub-
lished (61-63), containing additional information compared to
Bochicchio F.
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The perspectives include the followings: i) the publication of the
pooled results of 13 European studies, with a total of about 7000
cases and 14000 controls, expected in 2004; ii) the pooled analy-
sis of all the available case-control studies, which is expected to
be concluded in the 2005 or 2006; iii) the conclusion (probably in
the 2005) of a collaborative European study with the use of retro-
spective dosimetry on a sub-sample of subjects enrolled in previ-
ous studies, with a total of about 700 cases and 900 controls; iv)
the realization of new studies specifically addressed to the risk of
never-smokers and the interaction between radon and passive
smoking, and two such studies have been planned in USA and in
Italy.
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